Trastuzumab Injection should be administered subcutaneously or intravenously under the supervision of an experienced healthcare provider.
Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive.
Trastuzumab Injection should be administered subcutaneously or intravenously under the supervision of an experienced healthcare provider.
Most common side effects of Trastuzumab include headaches, dizziness, joint and muscle pain, rash, vomiting (being sick), breathlessness, flu-like symptoms, feeling sick, soreness at the injection site, diarrhoea, allergic reactions and blood clots.
Care should be exercised in the handling of HERTRAZ. Hertraz 440 mg Injection should be protected from light and should retain in the original carton until use. Store permitted between 2-8°C (36-46°F).
The active ingredient in the medicine is Trastuzumab, and the inactive ingredients are α,α-trehalose dihydrate, L-histidine HCl, L-histidine, and polysorbate 20.
Yes, Hertraz (Trastuzumab) is a breast cancer treatment medication.
Yes.
The medicine Trastuzumab is a mediator of antibody-dependent cellular cytotoxicity.
Patients can simply fill the order form or can send mail at info@ikrispharmanetwork.com. Patient can also send WhatsApp message to +91 8130290915. We will reply ASAP with the details of Pricing and procedure.
Note:- The order will be confirmed only after the receipt of Valid prescription of Clinician
Store the medicine at a temperature between 2-8°C (36-46°F).
All Trademark and Brand that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. Trastuzumab is a pharmaceutical drug that legally requires a medical prescription to be dispensed.
Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller and Pharmacies.